Andreea Barbu The Swedish Medical Product Agency

Andreea Barbu currently holds a position as senior assessor for biological medicinal products at the Medical Products Agency in Sweden, working with quality assessment and normative activities related to human and veterinary biological products, with special focus on advanced therapies and third generation vaccines. She is currently the vice-chair of the Biologics Working Party (BWP), a subgroup on biologics of the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency's (EMA). Since 2016 she is a member of the Cell Therapy Products Working Party under the European Directorate for the Quality of Medicines (EDQM). Before joining MPA, she has worked in academia, latest as Associated Professor in Experimental Endocrinology at Uppsala University. Her primary scientific activities involved evaluation of cell- and gene therapy strategies in the fields of diabetes and neuroendocrine tumors, as well as compatibility of biomaterials intended for combined cell-based therapies. AB graduated with a PhD in Medical Cell Biology from Uppsala University, Sweden.